Brighton Jones LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,405
Closed -$229K 490
2021
Q1
$229K Buy
+2,405
New +$229K 0.01% 367
2020
Q3
Sell
-3,206
Closed -$224K 346
2020
Q2
$224K Buy
+3,206
New +$224K 0.02% 264